Singapore markets close in 2 hours 4 minutes
Straits Times Index
3,306.16 +33.44 (+1.02%) Nikkei
38,460.08 +907.92 (+2.42%) Hang Seng
17,208.18 +379.25 (+2.25%) FTSE 100
8,044.81 +20.94 (+0.26%) Bitcoin USD
66,764.74 +357.71 (+0.54%) CMC Crypto 200
1,416.90 -7.20 (-0.51%)
Kronos Bio, Inc. (KRON)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 57.69M |
| Enterprise value | -87.03M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 8.82 |
| Price/book (mrq) | 0.36 |
| Enterprise value/revenue | -13.84 |
| Enterprise value/EBITDA | 0.73 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.83 |
| 52-week change 3 | -28.84% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 2.2900 |
| 52-week low 3 | 0.7310 |
| 50-day moving average 3 | 1.1438 |
| 200-day moving average 3 | 1.2648 |
Share statistics
| Avg vol (3-month) 3 | 350k |
| Avg vol (10-day) 3 | 595.81k |
| Shares outstanding 5 | 60.09M |
| Implied shares outstanding 6 | 60.09M |
| Float 8 | 43.75M |
| % held by insiders 1 | 19.58% |
| % held by institutions 1 | 44.68% |
| Shares short (28 Mar 2024) 4 | 665.01k |
| Short ratio (28 Mar 2024) 4 | 1.35 |
| Short % of float (28 Mar 2024) 4 | 1.42% |
| Short % of shares outstanding (28 Mar 2024) 4 | 1.11% |
| Shares short (prior month 29 Feb 2024) 4 | 600.42k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -994.36% |
Management effectiveness
| Return on assets (ttm) | -28.83% |
| Return on equity (ttm) | -55.84% |
Income statement
| Revenue (ttm) | 6.29M |
| Revenue per share (ttm) | 0.11 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -115.08M |
| Net income avi to common (ttm) | -112.67M |
| Diluted EPS (ttm) | -1.9500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 173M |
| Total cash per share (mrq) | 2.88 |
| Total debt (mrq) | 28.27M |
| Total debt/equity (mrq) | 17.77% |
| Current ratio (mrq) | 7.24 |
| Book value per share (mrq) | 2.70 |
Cash flow statement
| Operating cash flow (ttm) | -78.58M |
| Levered free cash flow (ttm) | -43.83M |
© 2024 Yahoo. All rights reserved.